ACT

June 14/2016

news roundup

Research Validates the Use of Shortened Consent Forms

ICON supported research with Carnegie Mellon University to evaluate patient-centric and patient-designed informed consent formats.

advertisment

Unlock the full potential of RBM using this new framework which integrates EDC with advanced RBM tools and goes beyond identifying risk to enable immediate action!
Listen to this podcast to learn how


Greenphire Joins SCRS Program

Greenphire will participate on the SCRS Global Impact Board and work with its Leadership Council.


DIA Exhibitor Profiles

Read more about the exhibitors at DIA, as well as speakers, news and podcasts with DIA presenters.

In this edition

DIA Exhibitor Profiles
Research Validates the Use of Shortened Consent Forms
Prepare for the ICH E6 (R2)
Mobile Health -- The Growing Availability of Wearable Devices

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Blog Posts

Avoid Shortcuts on Route to Data Anonymization

Expecting transparency requirements to grow, and building anonymization options into the original processes, is the best way life sciences organizations can stay ahead of the evolving requirements and minimize their risk.

Prepare for the ICH E6 (R2)

This change is likely to go into effect by the end of 2016, which means organizations that haven’t started transforming their risk monitoring process are already falling behind.

What Does Innovation Mean to You?

Take our survey today!


Mobile Health

The Growing Availability of Wearable Devices

Broad consumer use of such devices is building familiarity and will facilitate the implementation of similar medical grade devices in clinical studies.

Bracket Announces Suite of Mobile Applications

Bracket’s Patient Diary allows for clinical trial participants to record information during the trial using their smartphone.

Leveraging Site-Owned Tech to Improve Trial Retention

Patient-centric technologies should focus on enhancing patient and investigator communications.

Events

Publication and Clinical Trial Disclosure
Risk-Based Trial Management and Monitoring
Search more events

advertisment

The State of Risk-based Monitoring (RBM)
Live Webinar: Tuesday, June 21, 2016 at 11 am – 12 pm EDT
Register Free


Articles

Generic Drug Repurposing Clinical Trials

Development entities that support generic drug repurposing clinical trials are either commercial or philanthropic, and primarily in the unsolved disease area.

Adaptive Patient Recruitment

The idea behind “adaptive” is to use data in real time to protect on-time enrollment in a constantly changing recruitment landscape.


advertisment

BIOVISUALIZATION
Effective Mining and Interpretation of Laboratory Results Data

On Demand
Read more


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com

Advertise

Mike Tessalone
Publisher
mtessalone@advanstar.com